To understand more fully the clinicopathological features of primary gastri
c T-cell lymphomas (PGTL), we report two cases of PGTL and review the liter
ature. The present cases were not associated with human T-cell leukemia vir
us type 1 (HTLV-1) and were at clinical stage IIE. In both cases, T-cell or
igin of the lymphoma cells was diagnosed immunohistochemically. The clinica
l courses of these two cases were different: one followed a very aggressive
clinical course and the patient died 6 months after the diagnosis, whereas
the other patient survived more than 2 years without adjuvant chemotherapy
. Clinicopathological features of 23 patients with PGTL are summarized with
regard to their differences from primary small intestinal T-cell lymphomas
(PSITL) and by association with HTLV-1. The median age at onset of PGTL wa
s 58 years. The gender ratio was male-dominant (M:F = 2.3:1), About two-thi
rds (10 of 17) of PGTL cases had evidence of HTLV-1 infection. The most com
mon presenting symptom for PGTL was upper abdominal discomfort and/or pain
(76%), whereas that in PSITL was weight loss (61%) and diarrhea (42%). Typi
cal lesions for PGTL were large ulcerations at the corpus to antrum. Neopla
stic cells had no typical morphological characteristics for PGTL including
HTLV-l-associated cases. CD3+4+8- was the most frequently observed surface
phenotype of PGTL cells, Laboratory findings at diagnosis were not informat
ive. Most patients were treated by gastrectomy with or without chemotherapy
. PGTL, excluding that with HTLV-1, showed better prognosis than PSITL, alt
hough PGTL with HTLV-1 had a poorer prognosis.